World Cancer Day 2026

At 2Logical, we systematically assess the size and distribution of Oncology in Portugal, transforming fragmented data into structured and comparable insights.

In this particular Lung Cancer analysis, the data highlights that the care burden is not evenly spread. There’s a limited number of reference centers that manage the vast majority of cases. 

Top 3 National Accounts by Prevalence

LUNG CANCER

These Top 3 accounts manage 21% of all active patients nationwide.

Top 3 National Accounts by Incidence

LUNG CANCER

These Top 3 accounts manage 16% of all active patients nationwide.

In parallel, the regional analysis reveals marked territorial differences, with certain regions concentrating a disproportionate share of the national volume.

Territorial Differences in Volume

LUNG CANCER

In Oncology, this type of analysis is particularly valuable:

Understanding the true size of a market and how it’s distributed is essential for making decisions grounded in local clinical reality.

Where is the Industry Investing?

TOP ONCOLOGY AREAS BY REPORTED INVESTMENT

Total investment fell in 2025 , with Oncology’s share dropping from 12% to 10%. Despite this decline, spending shifted toward Healthcare Professionals (HCPs). 

While entities received 58% of funds in 2024, the distribution became more balanced in 2025 as HCP investment rose to 47%.

Recalled F2F Interactions Increased by 4,699 in 2025, Compared to 2024

The increase in F2F interactions in 2025 further confirms a strategic reinforcement of proximity with oncologists, positioning F2F as a key channel for high-value engagement in this specialty.

In Oncology, content effectiveness clearly varies by channel.

“The right channel, for the right content”

---

🎗️📊 When data is structured, consistent and clinically grounded, it changes how oncology is understood.

Reliable insights start with data quality, and that’s where meaningful analysis begin to create the conditions for more a informed, timely and patient-centred care.

On this World Cancer Day, we highlight the critical role of high-quality data in shaping a clearer understanding of the oncology landscape.